DV
Dividend Vision

VOR — Vor Biopharma Inc.

Vor Biopharma Inc. (VOR)

Total return is -96.9% over the past 5.5 years, 212.6 points behind SPY at 115.7%. Its deepest 1-year drawdown was 85.9%.

VOR is a healthcare equity stock that operates in the biopharmaceutical sector. As an individual stock rather than a diversified fund, it does not have a stated dividend distribution rate, expense ratio, or traditional fund characteristics. This holding appeals primarily to growth-oriented investors seeking exposure to the biotechnology industry rather than income-focused dividend investors.

VOR key facts

Asset type
Stock
Asset class
Equity
Inception date
02/05/2021
Distribution frequency
None
Last close
$23.03
Market cap
$1,362,507,776
Average volume
417600.0
Beta
1.721
Payout ratio
0.0
P/E ratio
0.129
Forward P/E
0.0
EPS
$178.49